Recent advances in the treatment of type 1 diabetes mellitus

被引:4
|
作者
Schloot, N. C. [1 ,2 ]
Roden, M. [1 ,2 ]
Bornstein, S. R. [3 ,4 ,5 ]
Brendel, M. D. [3 ,4 ,5 ]
机构
[1] Univ Dusseldorf, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, D-4000 Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Stoffwechselkrankheiten, Dusseldorf, Germany
[3] Carl Gustav Carus Univ, Med Klin & Poliklin 3, Univ Klinikum Dresden, Dresden, Germany
[4] Tech Univ Dresden, Paul Langerhans Inst Diabet Forsch, Dresden, Germany
[5] Ctr Regenerat Therapies, Dresden, Germany
关键词
type; 1; diabetes; immunoprevention; islet transplantation; pancreas transplantation; BETA-CELL FUNCTION; ISLET TRANSPLANTATION; DOUBLE-BLIND; INSULIN; INTERVENTION; SURVIVAL; PANCREAS; THERAPY; DISEASE; TRIAL;
D O I
10.1055/s-0031-1272502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interventional approaches to beta cell preservation: In a pilot study, initial attempts at primary prevention by preserving islet beta cells have been successful with highly hydrolyzed milk formula in children who are at high genetic risk of diabetes. Attempts at secondary prevention by intranasal application in children with a high-risk HLA genotype and positive islet autoantibodies have been disappointing. But in tertiary prevention anti-inflammatory, antigen-directed and T-cell targeted treatment has been partially successful in slowing down the destruction of beta cells. Biological beta cell substitution: Transplantation of a vascularised pancreas or islet cells results in disease regression and the prevention of secondary/tertiary complications of diabetes. A principal aim is the avoidance of frequent, severe hypoglycaemic episodes resulting from markedly reduced awareness of hypoglycaemia or its counter-regulation. © Georg Thieme Verlag KG Stuttgart New York.
引用
收藏
页码:172 / 175
页数:4
相关论文
共 50 条
  • [41] Recent developments in the treatment of type 2 diabetes mellitus
    Ruilope, LM
    CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (02) : 151 - 158
  • [42] Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials
    Min, Thinzar
    Bain, Stephen C.
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (01) : 1 - 15
  • [43] Brittle type 1 diabetes mellitus
    Bertuzzi, Federico
    Verzaro, Roberto
    Provenzano, Vincenzo
    Ricordi, Camillo
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (16) : 1739 - 1744
  • [44] Recent Developments in the Treatment of Type 2 Diabetes Mellitus
    Luis M. Ruilope
    Cardiovascular Drugs and Therapy, 2003, 17 : 151 - 158
  • [45] The challenge of type 1 diabetes mellitus
    Eiselein, L
    Schwartz, HJ
    Rutledge, JC
    ILAR JOURNAL, 2004, 45 (03) : 231 - 236
  • [46] Advances in Type 1 Diabetes Mellitus Management in Children
    Bahal, Mridu
    Pande, Vineeta
    Dua, Jasleen
    Mane, Shailaja
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [47] On type 1 diabetes mellitus pathogenesis
    Paschou, Stavroula A.
    Papadopoulou-Marketou, Nektaria
    Chrousos, George P.
    Kanaka-Gantenbein, Christina
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : R38 - R46
  • [48] Type 1 diabetes mellitus and pregnancy
    Golbert, Airton
    Campos, Maria Amelia A.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (02) : 307 - 314
  • [49] New advances in type 1 diabetes
    Subramanian, Savitha
    Khan, Farah
    Hirsch, Irl B.
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 384
  • [50] Prospects of a type 1 diabetes vaccine
    Cook, Dana P.
    Gysemans, Conny
    Mathieu, Chantal
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (04) : 403 - 406